KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Cash (2016 - 2025)

Historic Change in Cash for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$316.0 million.

  • Amgen's Change in Cash fell 11066.85% to -$316.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.8 billion, marking a year-over-year decrease of 37638.48%. This contributed to the annual value of -$2.8 billion for FY2025, which is 37638.48% down from last year.
  • Latest data reveals that Amgen reported Change in Cash of -$316.0 million as of Q4 2025, which was down 11066.85% from $1.4 billion recorded in Q3 2025.
  • Amgen's 5-year Change in Cash high stood at $23.9 billion for Q1 2023, and its period low was -$23.8 billion during Q4 2023.
  • Moreover, its 5-year median value for Change in Cash was -$303.0 million (2024), whereas its average is $143.2 million.
  • Its Change in Cash has fluctuated over the past 5 years, first skyrocketed by 930517.24% in 2021, then tumbled by 117052.86% in 2023.
  • Over the past 5 years, Amgen's Change in Cash (Quarter) stood at -$4.0 billion in 2021, then soared by 52.94% to -$1.9 billion in 2022, then crashed by 1170.53% to -$23.8 billion in 2023, then surged by 112.45% to $3.0 billion in 2024, then crashed by 110.67% to -$316.0 million in 2025.
  • Its Change in Cash was -$316.0 million in Q4 2025, compared to $1.4 billion in Q3 2025 and -$782.0 million in Q2 2025.